Sector#Biotechnology - Therapeutics
We create tailor-made antibodies and assays to quantify unique biomarkers in a wide variety of neurodegenerative diseases and conditions such as Alzheimer’s disease, Parkinson’s disease and traumatic brain injury. Our assays enable early detection before symptoms appear, providing valuable information from the drug development phase up to clinical practice, to improve the life of patients.
Upcoming eventsAll events
2211 '21Event by: VIB
2309 '21Event by: VIB
2004 '21Event by: SwedenBIO